Please login to the form below

12

Revenue 2017

Bayer

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bayer's 2013 sales performance.

Finalists

Switch 4 Them” - Protecting Vulnerable Patients During a Pandemic. by Bayer.

Amgen, Cytokinetics’ heart failure drug disappoints in phase 3

Also coming through the pipeline is Merck &Co and Bayer’s high-risk heart failure drug vericiguat which is currently being studied in patients with worsening chronic heart failure with reduced

Switzerland: a life sciences hub

The country is thus home to AbbVie, Allergan, Amgen, AstraZeneca, Bayer, Biogen, Boehringer Ingelheim, Eli Lilly, Gilead, GlaxoSmithKline, Janssen, Lundbeck, MSD (Merck Sharp &Dohme), Pfizer, Sanofi and Takeda among others.

AI: the smart money is on the smart thinking

Bayer and Merck &Co provide a perfect example of this. They have developed an AI software system to support clinical decision-making of chronic thromboembolic pulmonary hypertension (CTEPH) – a rare form ... Bayer and Merck &Co hope that radiologists

Merck, Bayer get FDA priority review for heart failure drug

Despite the mixed results, Merck and Bayer decided to take their chances and advanced the vericiguat clinical programme into phase 3. ... clinicians. With the FDA priority review in their pocket, Merck and Bayer can expect a decision by 20 January 2021.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

COVID-19 Updates and Daily News

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?: The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer: To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID-19 – a catalyst for technology adoption in clinical trials: As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...